Email Newsletters

Harvard Bioscience Inc.

Harvard Bioscience stock leaps on strong Q4 performance

Holliston biotechnology firm Harvard Bioscience returned to pre-COVID-19 revenue levels in the fourth quarter, but the company’s financial performance was still down overall for the year when compared to 2019.

Harvard Bioscience continues to improve financials following layoffs and closures

Holliston’s Harvard Bioscience has continued to correct course in the third quarter of the year after a rocky start to the year saw the company lose $4.5-million loss in the first quarter, according to its earnings report from Wednesday.

Following layoffs & closures, Harvard Bioscience improves financials

Holliston’s Harvard Bioscience has returned on course in the second quarter after a rocky start to the year, where it had a $4.5-million loss in the first quarter, according to its earnings report from Wednesday.

Harvard Bioscience announces $3.3M operating loss

Holliston’s Harvard Bioscience announced it had a $3.3-million operating loss in the first quarter of the year and predicted year-over-year losses would continue into the second quarter of the year.
- Advertisement -

Three Central Mass. public companies received $8.4M in PPP loans

Three public companies in Central Massachusetts have disclosed they received a combined $8.4 million in federal loans for the program intended to bailout small businesses.

Harvard Bioscience appeases activist investor with new board member

Holliston-based Harvard Bioscience announced Thursday that Susan Steele has been appointed to the company’s Board of Directors as a Class III director in a move to appease an activist investor company planning to nominate their own board member candidates.

Harvard Bioscience launches technology to help find coronavirus cure

Holliston biotechnology firm Harvard Bioscience, Inc. has developed a new technology to provide researchers with real-time access to aerosol amounts deposited inside subjects' lungs, the company said in a press release.

Harvard Bioscience laying off 10% of its workforce, closing Conn. operations

In its fourth-quarter earnings report released Wednesday, Holliston biotech Harvard Bioscience announced it has started a restructuring program expected to save about $4 million, including laying off workers and closing its facilities.
- Advertisement -

Harvard Bioscience hires robotic motion president as new EVP

Harvard Bioscience of Holliston has hired Yash Singh as an executive vice president to lead the newly formed cellular and molecular technologies team for the Holliston company.

Harvard Bioscience eyes 13% operating margin in 2021

Harvard Bioscience closed Monday trading up more than 10% after the Holliston biotech released a strategic action plan and financial targets through 2021.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

Retail and Customer Service Specialist

Girl Scouts of Central and Western Massachusetts
,
Worcester, MA
$20/hour

Communications & Events Coordinator

Girls Inc. of Worcester
,
Worcester, MA
Hourly Rate: $24–$27.88/hr (based on experience)

Chief Financial Officer

The Girl Scouts of Central and Western Massachusetts
,
Worcester, MA
$125,000 - $135,000
More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA